<unk>  is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein that is FDA approved for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.   Common adverse reactions include headache, nausea, abdominal pain, and vomiting.
Tecovirimat
Fomivirsen
Alcaftadine
Azatadine
Visnadine
Moxidectin
Peruvoside
Rimantadine